HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
Bristol Myers to Fund Inflammatory Bowel Disease Treg Therapies

GentiBio will use their proprietary regulatory T cell platform to develop the engineered therapies against multiple targets.

Shannon L. Maude, MD, PhD, on Favorable Safety of Tisagenlecleucel in Pediatric B-ALL

The oncologist from Children's Hospital of Philadelphia discussed long-term safety data with tisagenlecleucel in pediatric patients with acute lymphoblastic leukemia.

CGTLive’s Weekly Rewind – August 12, 2022

Review top news and interview highlights from the week ending August 12, 2022.

Zolgensma Gene Therapy Linked to 2 Deaths in SMA Patients, Novartis Reports

The 2 deaths, due to acute liver failure, occurred in patients treated in Kazakhstan and Russia.

ALS Cell Therapy Receives US Patent

AstroRx previously demonstrated clinically meaningful reductions in the rate of disease progression.

First Patient Dosed in Sickle Cell Gene Therapy Clinical Trial From Graphite Bio

Nula-cel is intended to directly correct the mutation that causes sickle cell disease.